Finally, Rizzolo et al. assessed promoter methylation in 69 male BC patients and concluded that alterations in methylation patterns were common in BC and might identify specific subgroups related to BRCA1/2 mutation status and some clinicopathologic parameters [21]. Here, BRCA1 is linked to breast cancer.